FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2064131567> ?p ?o ?g. }

• W2064131567 endingPage "103" @default.
• W2064131567 startingPage "99" @default.
• W2064131567 abstract "The cyclooxygenase-2 (COX-2) enzyme and major lipid product, prostaglandin E2 (PGE2) are elevated in many solid tumors including those of the breast and are associated with a poor prognosis. Targeting this enzyme is somewhat effective in preventing tumor progression, but is associated with cardiotoxic secondary effects when used chronically. PGE2 functions by signaling through four EP receptors (EP1-4), resulting in several different cellular responses, many of which are pro-tumorigenic, and there is growing interest in the therapeutic potential of targeting EP4 and EP2. Other members in this signaling pathway are gaining more attention. PGE2 is transported out of and into cells by two unique transport proteins. Multiple Drug Resistance-Associated Protein 4 (MRP4) and Prostaglandin Transporter (PGT) modulate PGE2 signaling by increasing or decreasing the levels of PGE2 available to cells. 15-hydroxyprostaglandin dehydrogenase (15-PGDH) metabolizes PGE2 and silences the pathway in this manner. The purpose of this review is to summarize the extensive data supporting the importance of the COX-2 pathway in tumor biology with a focus on more recently described pathway members and their role in modulating PGE2 signaling. This review describes evidence supporting roles for MRP4, PGT and 15-PGDH in several tumor types with an emphasis on the roles of these proteins in breast cancer. Defining the importance of these latter pathway members will be key to developing new therapeutic approaches that exploit the tumor-promoting COX-2 pathway." @default.
• W2064131567 created "2016-06-24" @default.
• W2064131567 creator A5045984557 @default.
• W2064131567 creator A5058380168 @default.
• W2064131567 date "2015-01-01" @default.
• W2064131567 modified "2023-09-23" @default.
• W2064131567 title "Multiple drug resistance-associated protein 4 (MRP4), prostaglandin transporter (PGT), and 15-hydroxyprostaglandin dehydrogenase (15-PGDH) as determinants of PGE2 levels in cancer" @default.
• W2064131567 cites W1500085124 @default.
• W2064131567 cites W1783009344 @default.
• W2064131567 cites W1829737408 @default.
• W2064131567 cites W1970873002 @default.
• W2064131567 cites W1972835138 @default.
• W2064131567 cites W1975705215 @default.
• W2064131567 cites W1979521500 @default.
• W2064131567 cites W1979538859 @default.
• W2064131567 cites W1984609427 @default.
• W2064131567 cites W1985446725 @default.
• W2064131567 cites W1991520741 @default.
• W2064131567 cites W1992576843 @default.
• W2064131567 cites W1993680782 @default.
• W2064131567 cites W1993824829 @default.
• W2064131567 cites W2010112169 @default.
• W2064131567 cites W2017440946 @default.
• W2064131567 cites W2018192635 @default.
• W2064131567 cites W2021225070 @default.
• W2064131567 cites W2027696344 @default.
• W2064131567 cites W2032614864 @default.
• W2064131567 cites W2034269086 @default.
• W2064131567 cites W2036299072 @default.
• W2064131567 cites W2038395070 @default.
• W2064131567 cites W2038766736 @default.
• W2064131567 cites W2040935952 @default.
• W2064131567 cites W2044939825 @default.
• W2064131567 cites W2050767064 @default.
• W2064131567 cites W2056709081 @default.
• W2064131567 cites W2056772956 @default.
• W2064131567 cites W2056978648 @default.
• W2064131567 cites W2065188145 @default.
• W2064131567 cites W2072957674 @default.
• W2064131567 cites W2076536269 @default.
• W2064131567 cites W2079799953 @default.
• W2064131567 cites W2080596524 @default.
• W2064131567 cites W2082140871 @default.
• W2064131567 cites W2083519527 @default.
• W2064131567 cites W2094402002 @default.
• W2064131567 cites W2096410299 @default.
• W2064131567 cites W2097145047 @default.
• W2064131567 cites W2098570483 @default.
• W2064131567 cites W2100642393 @default.
• W2064131567 cites W2104701964 @default.
• W2064131567 cites W2105517502 @default.
• W2064131567 cites W2106140153 @default.
• W2064131567 cites W2107369202 @default.
• W2064131567 cites W2116201618 @default.
• W2064131567 cites W2117692326 @default.
• W2064131567 cites W2120082193 @default.
• W2064131567 cites W2121451528 @default.
• W2064131567 cites W2131519618 @default.
• W2064131567 cites W2131578906 @default.
• W2064131567 cites W2132570017 @default.
• W2064131567 cites W2136689243 @default.
• W2064131567 cites W2138162756 @default.
• W2064131567 cites W2142112207 @default.
• W2064131567 cites W2143665747 @default.
• W2064131567 cites W2152064969 @default.
• W2064131567 cites W2154695733 @default.
• W2064131567 cites W2156734942 @default.
• W2064131567 cites W2158734599 @default.
• W2064131567 cites W2160886507 @default.
• W2064131567 cites W2170307903 @default.
• W2064131567 cites W2170955100 @default.
• W2064131567 cites W2171087521 @default.
• W2064131567 cites W4235607015 @default.
• W2064131567 doi "https://doi.org/10.1016/j.prostaglandins.2014.11.003" @default.
• W2064131567 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4385402" @default.
• W2064131567 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25433169" @default.
• W2064131567 hasPublicationYear "2015" @default.
• W2064131567 type Work @default.
• W2064131567 sameAs 2064131567 @default.
• W2064131567 citedByCount "43" @default.
• W2064131567 countsByYear W20641315672015 @default.
• W2064131567 countsByYear W20641315672016 @default.
• W2064131567 countsByYear W20641315672017 @default.
• W2064131567 countsByYear W20641315672018 @default.
• W2064131567 countsByYear W20641315672019 @default.
• W2064131567 countsByYear W20641315672020 @default.
• W2064131567 countsByYear W20641315672021 @default.
• W2064131567 countsByYear W20641315672022 @default.
• W2064131567 countsByYear W20641315672023 @default.
• W2064131567 crossrefType "journal-article" @default.
• W2064131567 hasAuthorship W2064131567A5045984557 @default.
• W2064131567 hasAuthorship W2064131567A5058380168 @default.
• W2064131567 hasBestOaLocation W20641315672 @default.
• W2064131567 hasConcept C134018914 @default.
• W2064131567 hasConcept C170493617 @default.
• W2064131567 hasConcept C178592051 @default.
• W2064131567 hasConcept C180899940 @default.
• W2064131567 hasConcept C2777956040 @default.

• next